SAN

76.52

+1.62%↑

UCB

261

+4.23%↑

SHL.DE

40.25

+1.13%↑

ARGX

637.8

+3.14%↑

PHIA

25.45

+2.95%↑

SAN

76.52

+1.62%↑

UCB

261

+4.23%↑

SHL.DE

40.25

+1.13%↑

ARGX

637.8

+3.14%↑

PHIA

25.45

+2.95%↑

SAN

76.52

+1.62%↑

UCB

261

+4.23%↑

SHL.DE

40.25

+1.13%↑

ARGX

637.8

+3.14%↑

PHIA

25.45

+2.95%↑

SAN

76.52

+1.62%↑

UCB

261

+4.23%↑

SHL.DE

40.25

+1.13%↑

ARGX

637.8

+3.14%↑

PHIA

25.45

+2.95%↑

SAN

76.52

+1.62%↑

UCB

261

+4.23%↑

SHL.DE

40.25

+1.13%↑

ARGX

637.8

+3.14%↑

PHIA

25.45

+2.95%↑

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Avatud

34.6 22.48

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

28.85

Max

34.85

Põhinäitajad
By Trading Economics
Sissetulek	-5.4M
Müük	27M
Kasumimarginaal	-20.208
Töötajad	103
EBITDA	1.1M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	-19.72% downside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	1. apr 2026

Turustatistika
By TradingEconomics
Turukapital	1.3B
Eelmine avamishind	12.12
Eelmine sulgemishind	34.6

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. märts 2026, 18:13 UTC

Omandamised, ülevõtmised, äriostud

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9. märts 2026, 17:20 UTC

Uudisväärsed sündmused

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9. märts 2026, 17:15 UTC

Omandamised, ülevõtmised, äriostud

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10. märts 2026, 00:00 UTC

Uudisväärsed sündmused

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9. märts 2026, 23:52 UTC

Market Talk

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9. märts 2026, 23:50 UTC

Market Talk

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9. märts 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. märts 2026, 23:46 UTC

Market Talk

Uudisväärsed sündmused

Correction to Crude Prices Market Talk on March 9

9. märts 2026, 23:42 UTC

Market Talk

Uudisväärsed sündmused

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9. märts 2026, 23:08 UTC

Uudisväärsed sündmused

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9. märts 2026, 23:07 UTC

Uudisväärsed sündmused

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9. märts 2026, 21:29 UTC

Omandamised, ülevõtmised, äriostud

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9. märts 2026, 21:28 UTC

Omandamised, ülevõtmised, äriostud

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9. märts 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. märts 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9. märts 2026, 20:47 UTC

Uudisväärsed sündmused

The 24 Hours When Oil Markets Went Wild -- WSJ

9. märts 2026, 20:33 UTC

Uudisväärsed sündmused

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9. märts 2026, 20:14 UTC

Market Talk

Uudisväärsed sündmused

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9. märts 2026, 19:33 UTC

Uudisväärsed sündmused

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9. märts 2026, 19:17 UTC

Market Talk

Uudisväärsed sündmused

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9. märts 2026, 19:14 UTC

Market Talk

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9. märts 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

9. märts 2026, 18:23 UTC

Market Talk

Uudisväärsed sündmused

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9. märts 2026, 17:58 UTC

Omandamised, ülevõtmised, äriostud

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9. märts 2026, 17:57 UTC

Omandamised, ülevõtmised, äriostud

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9. märts 2026, 17:41 UTC

Uudisväärsed sündmused

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9. märts 2026, 17:41 UTC

Market Talk

Uudisväärsed sündmused

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9. märts 2026, 17:08 UTC

Market Talk

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9. märts 2026, 17:04 UTC

Market Talk

Uudisväärsed sündmused

Global Forex and Fixed Income Roundup: Market Talk

9. märts 2026, 17:04 UTC

Market Talk

Uudisväärsed sündmused

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

-19.72% langus

12 kuu keskmine prognoos

Keskmine 23 EUR -19.72%

Kõrge 23 EUR

Madal 23 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.